Whether or not ergothioneine supplementation (25 mg given three times a week for 52 weeks) may be beneficial in delaying or reversing cognitive decline is the subject of an ongoing clinical trial in elderly individuals with mild cognitive impairment (79)
A basic dose log should include: date, time, dose in mg, concentration of vial, units drawn, injection site, and any side effects noted
How to position pasireotide LAR Treatment in Acromegaly
Although several clinical trials have been completed or are currently underway, repurposing GLP-1R agonists to treat cardiometabolic syndrome-related neurodegenerative diseases will require additional research to confirm safety and efficacy
Dosing is individualized and adjusted under medical supervision to support safety and treatment response
Melanoma: Dark, irregular mole that changes, possibly on thigh, shin, or knee